Computational Pathology, AI, and Diagnostic Innovation

Overview

Research in Computational Pathology, Artificial Intelligence (AI), and Diagnostic Innovation focuses on developing the computational infrastructure needed to turn complex biomedical data into actionable clinical insight. Faculty work at the intersection of pathology, machine learning, data science, and bioengineering to analyze digital pathology images, large-scale multi-omics datasets, and clinical genomic data, with the goal of improving disease diagnosis, biomarker discovery, and understanding of disease mechanisms.

Research programs build and apply AI-driven methods for analyzing digital pathology images, integrating genomic and clinical data, and identifying patterns that improve diagnostic accuracy and disease classification. Investigators also develop computational frameworks for interpreting single-cell sequencing, spatial transcriptomics, DNA methylation profiling, and immune repertoire analysis, alongside computational biology methods for interpreting genetic variants and transcriptional regulation in cancer and neurodegenerative diseases.

A distinguishing strength of the program is the integration of computational and experimental innovation. Faculty further engineer the experimental platforms that generate these data, including microfluidic and nanostructure systems for single-cell and exosome analysis, spatial multi-omic mapping technologies for tissue specimens, and machine learning approaches for histological and imaging analysis. Bioinformatics tools for clinical genomic interpretation in pediatric oncology and rare disease extend the program further into diagnostic practice.

Deeply collaborative by design, this program brings together clinicians, engineers, and biomedical informatics researchers across Penn Medicine and CHOP to move computational advances into deployment. The result is diagnostic tools and precision medicine strategies that sharpen clinical decision-making and improve patient care.

Faculty in this area of study 

Nicholas K. Brown, PhD, F(ACHI)
Informatics for clinical HLA and transplant immunology/immunogenetics

Timothy Chao, MD, PhD
AI-enhanced whole tissue imaging for histological analysis; AI-assisted discovery of novel histological diagnostic and prognostic features in diseases of the aerodigestive tracts

Yanxiang Deng, PhD
Spatial multi-omics profiling of epigenetic and transcriptional changes in tissues
Deng Lab Website

David E. Elder, MBChB
Diagnosis, prognosis, genetics and therapy of melanoma

R. Babak Faryabi, PhD
Molecular mechanisms regulating activity and spatial organization of cancer genomes
Faryabi Lab Website

Larissa V. Furtado, MD
Development, clinical implementation, and integration of genomic, epigenomic, bioinformatics, and artificial intelligence technologies in molecular pathology and precision oncology

Emma E. Furth, MD
Gastrointestinal, liver, biliary and pancreatic diseases; Mathematical modeling; Liver fibrosis mechanisms; Image analysis; Human and animal models of disease comparison; Immunohistochemistry

Saba Ghassemi, PhD
Engineering quiescent CART cells for adoptive immunotherapy; Enhancing CART cell function in solid tumors; Optimizing, streamlining, and automating the manufacturing process of CAR T cells
Ghassemi Lab Website

Mohammad (Mo) Haj-Dezfulian, PhD
TCR mapping technology to identify epitope specificity
Haj-Dezfulian Lab Website

Kester Haye, MD, PhD
Biomarkers of the GI tract; Tumor microenvironment in Pancreatic Adenocarcinoma; Tumor Microarray Development; Biomarker Development

Daniel S. Herman, MD, PhD
Development and application of computational approaches to improve the practice of laboratory medicine, with a focus on screening for underdiagnosed diseases
Herman Lab Website

Zhi Huang, PhD
Development of AI-based methods and platforms for histological analysis
Huang Lab Website

Jalal Badie Jalaly, MBBS, MS
HPV associated squamous cell carcinoma

Stephan Kadauke, MD, PhD
Improving access to CAR-T and ex vivo gene therapies through scalable care and delivery models; focus on hematopoiesis, gene editing, GMP, and international collaborations, with AI-enabled workflows
Kadauke Lab Website

Jina Ko, PhD
Micro-fluidics and nanostructure engineering; Single live cell and exosome proteomics and transcriptomics
Ko Lab Website

Pavel P. Kuksa, PhD
Scalable software platforms and data analysis algorithms for Alzheimer’s disease and related dementia genetics and functional genomics

Priti Lal, MD
Application of high through-put technology to gain insights into the biology of human cancers, with focus on renal, urothelial and prostate cancers

Wan-Ping Lee, PhD
Developing bioinformatics tools to discover human genomic variation, especially structural variants, to advance understanding of neurodegenerative disease mechanisms and genomic diversity across populations and individuals

Yuk Yee Leung, PhD
Genetics and genomics research investigating gene regulation, genomic variation, and functional mechanisms underlying development and disease using molecular, computational, and high-throughput approaches
Dr. Leung – LS Wang Lab

Bo Li, PhD
Computational, genomics, and machine learning approaches to develop immune-based biomarkers for early cancer detection and novel immunotherapies
Li Lab Website

Eline (Nina) T. Luning Prak, MD, PhD
Antibody repertoire in health and disease, B cell immunobiology, Autoimmunity, Diagnostic testing for autoimmune and infectious diseases
I3H – Luning Prak | Human Immunology Core | Colton Consortium – Luning Prak

Cindy M. McGrath, MD
Cervical cancer screening, diagnosis and management; HPV, digital cytopathology, FNA, ROSE, QA, Lab Operations

Jonni S. Moore, PhD
Technology development with a focus on complex technologies, in particular cytomics; development of high dimensional deep phenotyping approaches for the identification of biomarkers of cancer responses using advanced cytomic technology

MacLean Nasrallah, MD, PhD
Characterization and diagnosis of brain tumors with molecular studies, AI and imaging

Anupma Nayak, MBBS, MD
Clinical and translational research focusing on breast cancers; AI and omics to characterize biology of breast cancers; Developing strategies to reduce overdiagnosis and overtreatment in early-stage breast cancers; Biobanking

Roddy O'Connor, BSc, MS, PhD
CAR-T cell metabolism; metabolic gene enhancements; hypoxic conditioning; TME remodeling; TIL reinvigoration
O'Connor Lab Website

Derek Oldridge, MD, PhD
Bioinformatics and computational biology to analyze genomic data for clinical interpretation of genetic variants and optimize disease treatments in pediatric oncology
Oldridge Lab Website

Matthew B. Palmer, MD, PhD
Diabetic kidney disease classification and prognosis; mechanisms, models, and clinicopathologic studies of glomerular disease

Liming Pei, PhD
Molecular underpinnings of cardiac remodeling, metabolic reprogramming, and how heart-derived hormones communicate with other organs to maintain whole-organism homeostasis
Pei Lab Website

Olga Pozdnyakova, MD, PhD
AI-assisted diagnostic approach to hematologic neoplasms with the development of new testing algorithms and modalities; discovery of new morphologic, immunophenotypic and physical characteristics of hematopoietic cells for diagnosing and predictive models

Salvatore Fortunato Priore, MD, PhD
Clinical precision oncology test validation. Developing informatics tools to support clinical molecular biomarker testing workflows, data annotation and curation, reporting, and clinical decision support

Kyle G. Rodino, PhD, D(ABMM)
Translational assay development and implementation with diagnostic stewardship to optimize infectious diseases test delivery

Shefali Setia-Verma, PhD
Developing and implementing statistical methods and tools to model the underlying genetic mechanisms of complex human diseases
Setia-Verma Lab Website

Sydney M. Shaffer, MD, PhD
Lineage tracing in single cells using barcoding and mitochondrial sequencing to examine tumorigenesis
Shaffer Lab Website

Rajendra Singh, MBBS
Melanoma, Adnexal neoplasms, Digital Pathology, AI

Jasmine M. Vickery, MD
Breast pathology, specifically tumor biomarkers, invasive lobular carcinoma, multigenic tests and emerging molecular techniques, radiology-pathology correlation, AI applications, and diagnostic pathology/morphologic features

Kai Wang, PhD
Novel genomics and bioinformatics methods to analyze DNA/RNA sequencing data and application of AI in genomic medicine for rare diseases and cancer
Wang Lab Website

Li-San Wang, PhD
Computational biology of genetic variants and non-genetic transcriptional regulation in neurodegenerative disease
Wang Lab Website

Ping Wang, PhD, DABCC, FAACC
Innovative diagnostics development and translation, including Clinical Chemistry, Point-of-care Testing, Toxicology, Clinical Mass Spectrometry and Molecular Diagnostics
Wang Lab Website

Matthew D. Weitzman, PhD
How human DNA viruses like adenovirus and HSV-1 manipulate cellular DNA repair and RNA processing pathways to promote infection and replication
Weitzman Lab Website

Robert B. Wilson, MD, PhD
Neurodegenerative disorders, Friedreich ataxia
Wilson Lab Website

Yi Xing, PhD
RNA processing (alternative splicing, modifications) in human health, disease, and cancer immunotherapy using computational and genomic biology
Xing Lab Website

Xiaowei (George) Xu, MD, PhD
CART cell and extracellular vesicle-based therapies for melanoma

Zhaohai Yang, MD, PhD
Neoplastic diseases of the luminal gastrointestinal tract, liver, biliary tract, and pancreas, with a particular interest in neuroendocrine tumors of the digestive system

Mark D. Zarella, PhD
Direct tissue and 3D optical imaging; Imaging informatics; Artificial intelligence development and implementation best practices
Zarella Lab Website

Wanding Zhou, PhD
Computational epigenetics (DNA methylation) for cell identity and mitotic history in pediatric malignancies and developmental abnormalities
Zhou Lab Website

Visit our Research at Penn website.